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Abstract
Background: Intradialytic hypotension (IDH) is considered one of the most frequent complications of
haemodialysis with an estimated prevalence of 20–50 %, but studies investigating its exact prevalence are scarce.
A complicating factor is that several definitions of IDH are used. The goal of this study was, to assess the prevalence
of IDH, primarily in reference to the European Best Practice Guideline (EBPG) on haemodynamic instability: A
decrease in systolic blood pressure (SBP) ≥20 mmHg or in mean arterial pressure (MAP) ≥10 mmHg associated with
a clinical event and the need for nursing intervention.
Methods: During 3 months we prospectively collected haemodynamic data, clinical events, and nursing
interventions of 3818 haemodialysis sessions from 124 prevalent patients who dialyzed with constant ultrafiltration
rate and dialysate conductivity. Patients were considered as having frequent IDH if it occurred in >20 % of dialysis
sessions.
Results: Decreases in SBP ≥20 mmHg or MAP ≥10 mmHg occurred in 77.7 %, clinical symptoms occurred in
21.4 %, and nursing interventions were performed in 8.5 % of dialysis sessions. Dialysis hypotension according to
the full EBPG definition occurred in only 6.7 % of dialysis sessions. Eight percent of patients had frequent IDH.
Conclusions: The prevalence of IDH according to the EBPG definition is low. The dominant determinant of the
EBPG definition was nursing intervention since this was the component with the lowest prevalence. IDH seems to
be less common than indicated in the literature but a proper comparison with previous studies is complicated by
the lack of a uniform definition.
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Background
Intradialytic hypotension (IDH) is considered one of
the most frequent complications of haemodialysis
treatment and is associated with increased cardiovas-
cular morbidity and mortality [1]. Various reviews re-
port that up 50 % of haemodialysis sessions are
complicated by IDH [2–9]. However, studies on the
prevalence of IDH are relatively scarce [10–13] and
most of these studies were conducted more than
10 years ago [10, 11, 13]. Since then, dialysis tech-
niques have improved and there is more awareness of
strategies to prevent IDH, e.g. by lowering the dialys-
ate temperature [14, 15] and monitoring of relative
blood volume changes [16]. At the same time, the
average age of dialysis patients as well as the propor-
tion of patients with significant co-morbidities such
as diabetes mellitus and heart failure has increased
[17, 18]. It follows that the current prevalence of IDH
is unknown.
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A complicating factor in the analysis of IDH is that
many different definitions of hypotension are used in the
literature. These vary from liberal definitions that only
require a minimum fall (e.g. ≥20 or ≥30 mmHg) in sys-
tolic blood pressure (SBP) [19–21] to strict definitions
that require the combination of a clinical event and a
nursing intervention in addition to a minimum fall in
blood pressure [22–24]. The European Best Practice
Guideline (EBPG) on haemodynamic instability defines
IDH as a decrease in SBP ≥20 mmHg or a decrease in
mean arterial pressure (MAP) by ≥10 mmHg associated
with a clinical event and the need for a nursing interven-
tion [22]. To the best of our knowledge, there are only
two small studies that investigated the prevalence of
IDH according to the EBPG definition [24, 25].
The goal of this study was to assess the prevalence of
IDH and to identify patient and treatment factors that are
associated with its presence. For this purpose, we pro-
spectively collected the haemodynamic data, clinical
events and nursing interventions of 3818 dialysis sessions
from 124 patients. We primarily used the EBPG definition
[22] and studied in detail the prevalence of the separate
items of this definition to get a better insight in their rela-
tive contributions to the definition. Additionally, we com-
puted the prevalence of IDH using additional cut-off
values for the required blood pressure drop (≥30 mmHg
and ≥40 mmHg). These analyses facilitate the comparison
of the prevalence of IDH in our population with previous
studies that used other definitions.
Methods
Patients
This multicenter prospective observational study included
adult (≥18 years) incenter haemodialysis patients from the
Dialysis Center Groningen and the dialysis unit of the
University Medical Center Groningen (Fig. 1). They were
eligible for the study when they fulfilled the following cri-
teria: maintenance bicarbonate haemodialysis for more
than 3 months, three times a week 3.5 to 4.5 h haemodi-
alysis schedule.
This observational study was conducted without inter-
vention or obtaining any patient material. The laboratory
measurements described in this manuscript were per-
formed as part of clinical routine. Therefore, according
to Dutch legislation, an ethic statement for approval by
the local Medical Ethical Committee (University Medical
Center Groningen) was not necessary. All personal in-
formation was de-identified and analyzed anonymously.
Patients gave oral informed consent. The study was per-
formed in accordance with the principles of the Declar-
ation of Helsinki.
Study protocol
During 3 months (February, March and April) we
prospectively collected the haemodynamic data of all
the haemodialysis sessions from participating patients.
At each session, patients were evaluated for pre- and
postdialysis weight and pre-, intra-, and postdialysis
blood pressures and heart rate, ultrafiltration volume,
and the occurrence of clinical events possibly related
to dialysis hypotension, and nursing interventions.
Clinical events were defined as nausea, dizziness,
light-headedness, fatigue occurring during haemodialy-
sis, muscle cramps, loss of consciousness or any other
additional complaint that was related to the dialysis
procedure as judged by the patient and/or nurse (mis-
cellaneous clinical events). Nursing interventions were
defined as temporary interruption of ultrafiltration,
Trendelenburg position, and administration of
Adult patients undergoing haemodialysis 
in DCG and UMCG: n=183
Patients not fulfilling the inclusion criteria: n=35
- Haemodialysis less than 3 months: n=19  
- Other schedules than thrice weekly 3.5-4.5hours: n=16
Eligible for the study: n= 148
No informed consent: n=24
Study population: n=124 
Fig. 1 The details of patient selection
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intravenous fluids. All data were registered on a run
sheet and stored electronically.
Blood pressure and heart rate were measured with
an automated oscillometric monitor at standardized
intervals: before haemodialysis, at 10, 30, 60, 120, and
180 min intra-dialysis, and at the end of the dialysis
session (240 min of dialysis). Haemodialysis sessions
during hospitalization were excluded from the ana-
lysis. Prescriptions regarding dry weight and antihy-
pertensive medication were made by the nephrologists
during their weekly visit to the participating patients.
Dry weight was evaluated clinically (peripheral edema,
signs of pulmonary congestion, intra- and extra-
dialytic blood pressure course, muscle cramps) and by
the cardiopulmonary radiological aspect. Ultrafiltra-
tion rate was calculated by dividing ultrafiltration vol-
ume by dialysis session length.
Cardiovascular history was defined as any history of is-
chemic heart disease, congestive heart failure, stroke or
peripheral vascular disease. Residual diuresis was defined
as ≥200 ml/day. Equilibrated Kt/V was calculated from
pre- and postdialysis plasma urea concentration accord-
ing to the second-generation logarithmic Daugirdas
equation [26].
Dialysis hypotension was primarily defined according
to the EBPG definition [22] as a decrease in SBP
≥20 mmHg or a decrease in MAP by ≥10 mmHg associ-
ated with a clinical event and need for nursing interven-
tions. Patients were considered to have frequent dialysis
hypotension when they fulfilled the full EBPG definition
of dialysis hypotension in ≥20 % of dialysis sessions. In
separate analyses, we additionally studied the prevalence
of dialysis hypotension using different cut-off values
(≥30 mmHg and ≥40 mmHg) as the required blood
pressure drop.
Dialysis settings
All patients were dialysed with bicarbonate dialysis,
thrice weekly for 3.5 to 4.5 h with a low-flux polysul-
phone hollow-fiber dialyser, F8 or F10 (Fresenius Med-
ical Care, Bad Homburg, Germany). Blood flow rates
ranged between 250 and 350 ml/min. The dialysate flow
rate was 500 or 700 ml/min. The blood flow and dialys-
ate flow were kept constant throughout the study period
in the individual patient. All patients were dialyzed with
a constant dialysate conductivity of 13.9 mS/cm and a
constant ultrafiltration rate. The dialysate temperature,
36.0 or 36.5 °C, was kept constant during the study
period for the individual patient. The dialysate compos-
ition was as follows: sodium 139 mmol/l, potassium 1.0
or 2.0 mmol/l, calcium 1.5 mmol/l, magnesium
0,5 mmol/l, chloride 108 mmol/l, bicarbonate 34 mmol/
l, acetate 3 mmol/l, glucose 1.0 g/l. Patients received a
light meal and two cups of coffee or tea during haemodi-
alysis as usual.
Statistical analysis
Continuous variables with normal distributions are
reported as mean ± SD, skewed data as median (inter-
quartile range), and categorical data by number (per-
centage). Normality was tested with the Shapiro
Wilkinson test. Comparisons of variables with a normal
distribution were made with the T-test and comparisons
of variables with a skewed distribution were performed
with the Mann Whitney U test.
For the analysis of the determinants of dialysis
hypotension a multivariate repeated generalized (logistic)
linear mixed model was estimated [27] followed by a
model building strategy based upon the Bayesian Infor-
mation Criterion (BIC model) [28]. The following pa-
rameters were included: age, sex, body weight, body
height, Body Mass Index (BMI), dialysis vintage, residual
kidney function, diabetic status, Kt/V, haemoglobin,
plasma albumin concentration, haemodialysis access
(central venous catheter versus fistula), ultrafiltration
volume, ultrafiltration rate, bloodflow, predialysis SBP,
predialysis diastolic blood pressure (DBP), predialysis
heartrate, comorbid conditions of ischemic heart disease
and congestive heart failure and use of cardiovascular
medication. Each parameter was used as covariate in an
repeated logistic regressions analysis, taking the patient
as random effect.
Analyses were performed with SPSS version 20.0,
GraphPad Prism version 5.0 and statistical programming
language R (R Development Core Team (2011). Two




One hundred twenty-four patients were included in this
study. Patient characteristics are shown in Table 1. Mean
(±SD) haemoglobin and albumin levels were 6.9 ±
0.8 mmol/l and 39.2 ± 3.2 g/l, respectively. eKt/V was
1.32 ± 0.36 per session. Haemodialysis access was an
arterio-venous fistula or polytetrafluoroethylene (PTFE)
graft in 77 % of patients and a tunneled central venous
catheter in 23 % of patients. Cardiovascular medication
was used by 67 % of the patients.
In total 3818 haemodialysis sessions were analyzed.
The average number of dialysis sessions per patient was
32 (range 9–36).
Weight, ultrafiltration volume, blood pressure, and heart
rate
The average pre- and postdialysis body weight was
74.7 ± 15.8 kg and 72.8 ± 15.8 kg, respectively. The
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average ultrafiltration volume and ultrafiltration rate
in all 3818 dialysis sessions was 2386 ± 834 ml and
8.5 ± 3.3 ml/kg/h, respectively.
Average courses of blood pressure and heart rate of
the 3818 dialysis sessions are shown in Fig. 2. The lowest
blood pressure was documented at the end of the dialy-
sis session. Blood pressure decreased from 146 ± 27/72
± 15 mmHg predialysis to 120 ± 27/63 ± 15 mmHg at the
end of the dialysis session. The average MAP decreased
from 97 ± 16 mmHg predialysis to 82 ± 17 mmHg post-
dialysis. Heart rate rose from 75 ± 12 mmHg predialysis
to 77 ± 16 beats/min at the end of the dialysis sessions.
The average change in SBP, DBP and MAP from predia-
lysis to the end of the dialysis sessions was −23 ± 26, −9
± 14, and −14 ± 17 mmHg, respectively. The average
change in heart rate from pre to postdialysis sessions
was +1.6 ± 12.9 beats/min (Fig. 2).
Prevalence of hypotension, clinical events and nursing
interventions
As much as 63.8 % of dialysis sessions were complicated
by a decrease in SPB of ≥20 mmHg (Table 2). A decrease
in MAP ≥10 mmHg occurred in 71.2 % of dialysis ses-
sions. A decrease in SBP of ≥20 mmHg or MAP ≥ 10
was present in 77.7 % of dialysis sessions.
A total of 21.4 % of dialysis sessions was complicated
by a clinical event. The most frequent clinical event was
muscle cramp, occurring in 8.8 % of dialysis sessions
(Table 2). Nursing interventions were carried out in
8.5 % of dialysis sessions. The most frequent nursing
intervention was stop of ultrafiltration, which was ap-
plied in 7.0 % of dialysis sessions.
Figure 3 shows the relations and overlap of the 3 com-
ponents of the EBPG definition of IDH. Notably, in most
(58.2 %) dialysis sessions that fulfilled the hypotension
component of the EBPG definition, there was no clinical
event or intervention. In another 11.7 % of dialysis ses-
sions that fulfilled the hypotension component of the def-
inition, a clinical event occurred but no nursing
intervention was carried out. A combination of a decrease
in SBP of ≥20 mmHg or MAP ≥ 10 mmHg with a clinical
event and nursing intervention (full EBPG definition) oc-
curred in 6.7 % of dialysis sessions. Of the dialysis sessions,
3.0 % were complicated by a clinical event without fulfill-
ing the hypotension component of the definition. In 0.5 %
of dialysis sessions, both a clinical event occurred and a
nursing intervention was performed without fulfilling the
hypotension component of the definition.
Prevalence of dialysis hypotension using alternative
cut-off values for the fall in SBP
Additional file 1 shows the frequencies of the 3 compo-
nents of the definition using different cut-off values for
the reduction in SBP: a fall in SBP ≥30 mmHg (present
in 43.5 % of dialysis sessions) and a fall in SBP
≥40 mmHg (present in 27.4 % of dialysis sessions). A de-
crease in SBP ≥30 mmHg in combination with a clinical
event and a nursing intervention was present in 5.6 % of
the dialysis sessions. A decrease in SBP ≥40 mmHg in
combination with a clinical event and a nursing inter-
vention was observed in 4.6 % of the dialysis sessions.
We also computed the prevalence of intradialytic
hypotension according to nadir-based definitions (as re-
cently described by Flythe et al.) [29]. As shown in Add-
itional file 2 the prevalence of intradialytic hypotension
according to the nadir of SBP <90 mmHg in combin-
ation with a fall in of ≥20 or ≥30 mmHg was 9.2 % and
7.1 %, respectively.
Prevalence of dialysis hypotension at patient level
Since the occurrence of dialysis hypotension may not be
evenly distributed over patients, we also analyzed which
Table 1 Patient characteristics
Characteristic n = 124
Age, year 64.1 ± 15.7
Dialysis vintage, months 32.0 ± 30.7
Males 69 (56)
Diabetics 31 (27)
Body mass index (kg/m2) 25.3 ± 4.9
Number of patients with residual renal function 26 (21)
Cardiovascular history 39 (31)
Acute myocardial infarction 8 (6.5)
Congestive heartfailure 9 (7.3)
Peripheral vascular disease 25 (20.2)





Obstructive uropathy 17 (14)
ADPKD 10 (8)
IgA nephropathy 6 (5)
Alports’ disease 2 (2)






Categorical variables are presented as number (percentage); continuous
variables are presented as mean ± standard deviation
Abbreviations: ADPKD autosomal dominant polycystic kidney disease, CCB
calcium channel blocker, ACE-I angiotensin converting enzyme inhibitor, ARB
angiotensin receptor blocker
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Fig. 2 Average courses of systolic blood pressure, diastolic blood pressure, mean arterial pressure, and heart rate. Each line represents the mean
value of the 3818 haemodialysis sessions. The error bars represent the 95 % confidence interval
Kuipers et al. BMC Nephrology  (2016) 17:21 Page 5 of 11
proportion of patients fulfilled the separate items as well
as the full EBPG definition. We specifically analyzed
which proportion of patients fulfilled the EBPG criteria
for IDH in 0 to 10 %, in 10 to 20 % or in >20 % of dialy-
sis sessions. We found that 89.9 % of patients had a de-
crease in SBP of ≥20 mmHg in more than 20 % of
dialysis sessions (Table 3). As much as 96.8 % of patients
had either a decrease in SBP of ≥20 mmHg or a decrease
in MAP ≥ 10 in more than 20 % of dialysis sessions.
Ten (8.1 %) patients fulfilled the full EBPG definition
of dialysis hypotension in more than 20 % of dialysis ses-
sions (Table 3).
Similar analyses were performed for alternative
cut-offs for SBP showing that 74.2 % of patients
had a decrease in SBP ≥30 mmHg and 52.4 %
of patients had a decrease in SBP ≥40 mmHg in
more than 20 % of the dialysis sessions. A total
of 6.5 % of patients had a decrease in SBP
≥30 mmHg in combination with a clinical event
and a nursing intervention in more that 20 % of
dialysis sessions; 5.6 % of patients had a decrease
in SBP ≥40 mmHg in combination with a clinical
event and a nursing intervention in more than
20 % of dialysis sessions.
Table 2 Prevalence of blood pressure drop, clinical events, and nursing interventions in all 3818 haemodialysis sessions
Nr of dialysis sessions (%)
Blood pressure drop
Decrease in SBP ≥20 mmHg 2434 (63.8)
Decrease in MAP of ≥10 mmHg 2719 (71.2)
Decrease in SBP ≥20 mmHg or in MAP ≥10 mmHg 2966 (77.7)
Clinical events






Loss of consciousness 20 (0.5)
Miscellaneous 233 (6.1)
Nursing interventions
Any nursing intervention 326 (8.5)
Stop of ultrafiltration 267 (7.0)
Trendelenburg position 219 (5.7)
Administration of isotonic saline 132 (3.5)
Administration of colloid solution 47 (1.2)
BP drop in combination with a clinical event
Decrease in SBP ≥20 mmHg 610 (16.0)
Decrease in MAP ≥10 mmHg 662 (17.3)
Decrease in SBP ≥20 mmHg or decrease in MAP ≥10 mmHg 701 (18.4)
BP drop in combination with a nursing intervention
Decrease in SBP ≥20 mmHg 285 (7.5)
Decrease in MAP ≥10 mmHg 288 (7.5)
Decrease in SBP ≥20 mmHg or decrease in MAP ≥10 mmHg 300 (7.9)
BP drop in combination with a clinical event and nursing intervention
Decrease in SBP ≥20 mmHg 242 (6.3)
Decrease in MAP ≥10 mmHg 247 (6.5)
Decrease in SBP ≥20 mmHg or in MAP ≥10 mmHg (full EBPG definition) 256 (6.7)
Values are given as number (percentage)
The total number of patients with clinical events and nursing interventions is lower than the separate items since some patients had more than one clinical event
and/or intervention
Abbreviations: BP blood pressure, SBP systolic blood pressure. MAP mean arterial blood pressure
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Intradialytic blood pressure and heart rate in patients
with and without frequent dialysis hypotension
Patients who experienced frequent dialysis hypotension
according to the full EBPG definition had significantly
higher predialysis SBP (P = 0.001) and a greater decline in
SBP during dialysis in comparison with patients without
frequent IDH (Fig. 4). Predialysis heart rate was signifi-
cantly lower in patients with frequent IDH (P = 0.001)
compared with patients without frequent IDH. The pro-
portion of patients that used a beta-blocker did not differ
between these 2 groups, 70 % and 57 % in patients with
and without frequent IDH, respectively (Additional file 3).
Variables associated with intradialytic hypotension
according to the EBPG definition
In univariate analysis, the following parameters had a
significant association with the occurrence of dialysis
hypotension according to the EBPG guideline: female
sex, lower body weight, lower body height, absence of
residual kidney function, higher plasma albumin concen-
tration, higher ultrafiltration volume, and higher dialysis
vintage (Table 4).
The BIC model building strategy showed that the oc-
currence of dialysis hypotension according to the full
EBPG definition was strongly associated with lower body
Fig. 3 Proportional Venn-diagram showing the relationship and overlap between the blood pressure drop (a decrease in systolic blood pressure
SBP of ≥20 mmHg or a decrease in MAP≥ 10 mmHg)
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height (p = 0.0001) and a higher ultrafiltration volume
(p = 0.0004) (Additional file 4).
Discussion
The main finding of this study is that the prevalence of
dialysis hypotension when applying the EBPG definition
was relatively low and occurred in only 6.7 % of dialysis
sessions. Frequent dialysis hypotension, tentatively de-
fined as dialysis hypotension in more than 20 % of dialy-
sis sessions, was observed in 8.1 % of patients.
In various reviews, it is stated that 20–50 % of haemo-
dialysis sessions are complicated by dialysis hypotension
[2–7, 9]. However, in the limited number of studies on
this topic, the prevalence of dialysis hypotension was
lower, ranging between 2 % and 30 % of dialysis sessions
[12, 13, 25]. It should be noted that these studies used
different definitions of dialysis hypotension, which com-
plicates a proper comparison with our study. To the best
of our knowledge, there are only 2 other studies that in-
vestigated the prevalence of dialysis hypotension as de-
fined according to the definition in the EBPG guideline
on haemodynamic stability. The prevalence of dialysis
hypotension according to this definition in these studies
was 5.0 % [25] and 11.2 % [24].
Our study shows that dialysis hypotension according
to the EBPG definition is relatively rare (6.7 % of ses-
sions). Even if we use a more liberal definition, e.g., a fall
in SBP >20 mmHg or a fall in MAP >10 mmHg in com-
bination with a clinical event (thus without the need for
nursing intervention), the prevalence of dialysis
hypotension is 18.4 % which is still lower compared with
the prevalence of 20–50 % stated in most reviews. It is
unlikely that our study underestimated the true
prevalence of dialysis hypotension since blood pressure
was measured much more frequently than is usual in
clinical practice, facilitating the finding of a minimum
reduction in blood pressure. In addition, both patients
and nurses were instructed to register any complaint or
symptom that could be related to dialysis hypotension.
It is evident that the prevalence of dialysis hypotension
is influenced by the dialysis settings. Shorter treatment
times [7, 30], higher ultrafiltration rates [31] and rela-
tively high dialysate temperatures [14, 15] are all risk
factors for dialysis hypotension. Notably, in the present
study dialysis duration was 3.5, to 4.5 h, ultrafiltration
rate was relatively low (8.5 ± 3.3 ml/kg/h) and dialysate
temperature was set at 36.0 or 36.5 °C. These dialysis
settings may have contributed to the low prevalence of
dialysis hypotension in our study relative to other
studies.
A fall in SBP ≥20 mmHg or a fall in MAP ≥10 mmHg
occurred in more than three quarters of dialysis sessions.
At patient level, as much as 96.8 % of patients had a de-
crease in SBP ≥20 mmHg or a decrease in MAP ≥
10 mmHg in more than 20 % of dialysis sessions. It fol-
lows that a decrease in SBP ≥20 mmHg or a fall in
MAP ≥ 10 mmHg is so common that it is not specific
for symptomatic dialysis hypotension. Notably, in most
(58.2 %) dialysis sessions that fulfilled the hypotension
component of the EBPG definition, there was no clinical
event or intervention. This raises the question whether a
decrease in SBP ≥20 mmHg or a decrease in MAP ≥
10 mmHg discriminates between patients with and with-
out symptomatic dialysis hypotension. Various factors
may affect predialysis blood pressure like stress due to
transportation to the dialysis unit and anxiety for
Table 3 Frequency of blood pressure drop, clinical events, and nursing interventions at patient level in 124 patients
Number of patients, n (%)
In <10 % of dialysis
sessions
In 10–20 % of dialysis
sessions
In ≥20 % of dialysis
sessions
Blood pressure drop
Decrease in SBP ≥20 mmHg 3 (2.4) 10 (8.1) 111 (89.5)
Decrease in MAP ≥10 mmHg 0 5 (4.0) 119 (96.0)
Decrease in SBP ≥20 mmHg or in MAP ≥10 mmHg 0 4 (3.2) 120 (96.8)
Clinical event 45 (36.2) 31 (25.0) 48 (38.8)
Nursing intervention 93 (75.0) 16 (12.9) 15 (12.1)
Clinical event and nursing intervention 99 (79.8) 15 (12.1) 10 (8.1)
BP drop in combination with clinical event and nursing
intervention
Decrease in SBP ≥20 mmHg 101 (81.5) 13 (10.4) 10 (8.1)
Decrease in MAP ≥10 mmHg 102 (82.2) 12 (9.7) 10 (8.1)
Decrease in SBP ≥20 mmHg or decrease in 101 (81.5) 13 (10.4) 10 (8.1)
MAP ≥10 mmHg (EBPG definition)
Values are given as number (percentage)
Abbreviations: BP blood pressure, SBP systolic blood pressure, MAP mean arterial blood pressure
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Fig. 4 Average course of systolic blood pressure, diastolic blood pressure, mean arterial pressure, and heart rate for haemodialysis sessions of
patients with (n = 10) and without (n = 114) frequent dialysis hypotension according to the EBPG definition in ≥20 % of haemodialysis sessions.
The error bars represent the 95 % confidence interval
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puncture of the fistula. When predialysis blood pressure
is used as the reference point, part of the early intradia-
lytic fall in blood pressure may be explained by the relief
of stress/anxiety, e.g. after successful puncture of the fis-
tula, and not by dialysis-specific haemodynamic stress.
Conversely, haemodialysis may exert haemodynamic
stress, including cardiac stunning, even in the absence of
a significant blood pressure drop [32]. Indeed, in this
study, 3.0 % of dialysis sessions were complicated by a
clinical event without fulfilling the hypotension compo-
nent of the definition. In our view, the starting point for
a definition of symptomatic dialysis hypotension should
be the occurrence of a clinical event and/or a nursing
intervention instead of a minimum fall in SBP.
In a composited definition as the EBPG definition, the
prevalence of dialysis hypotension can never be higher
than the component with the lowest prevalence. The
component with the lowest prevalence in this study was
nursing intervention.
In multivariate analyses, the strongest determinants of
dialysis hypotension defined by the full EBPG definition
were lower body height and higher ultrafiltration vol-
ume. Where there is abundant literature linking dialysis
hypotension to higher ultrafiltration volumes and ultra-
filtration rate [9, 17, 33], the association between dialysis
hypotension and lower body height has not been de-
scribed before. This could be related to an unfavorable
balance between ultrafiltration rate and refill rate in
smaller patients.
A limitation of our study is that we did not use an ob-
jective method to assess dry weight, e.g. bioimpedance.
Therefore, we cannot exclude that a proportion of pa-
tients were not at their true dry weight at the end of dia-
lysis which may have affected the course of blood
pressure as well as the frequency of clinical events and
nursing interventions. Bias in blood pressure measure-
ments could be introduced by underlying vascular dis-
ease. Finally, it should be noted that the EBPG
definition, like any other definition using clinical symp-
toms or nursing interventions is subject to bias. The
interpretation of patient complaints as part of the symp-
tomatology of dialysis hypotension as well as the thresh-
old to perform an intervention may differ between
nurses (and between physicians). Strong points of our
study are the relatively long study duration of 3 months
and the frequent measurement of blood pressure (and
active search for patient complaints at each dialysis ses-
sion) which reduced the chance of underestimation of
dialysis hypotension.
Conclusion
In conclusion, the prevalence of dialysis hypotension ac-
cording to the EBPG definition is low. The dominant de-
terminant of the EBPG definition was nursing
intervention since this was the component with the low-
est prevalence. Dialysis hypotension might be less com-
mon than indicated in the literature however a proper
comparison with previous studies is complicated by the
lack of a uniform definition.
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Table 4 Variables that are significantly associated with the occurrence of dialysis hypotension according to the full EBPG definition
in univariate analysis
Odds of dialysis hypotension
Estimate SE Z P Lower 95 % CI Upper 95 % CI Estimate Lower 95 % CI Upper 95 % CI
Sex (female vs male) 0.695 0.289 2.409 0.016 0.128 1.277 2.004 1.137 3.586
Body weight (kg) −0.022 0.009 −2.338 0.019 −0.041 −0.004 0.979 0.960 0.996
Body height (m) −0.048 0.015 −3.282 0.001 −0.077 −0.019 0.953 0.926 0.980
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Albumin (g/l) 0.108 0.048 2.232 0.026 0.014 0.207 1.114 1.014 1.229
Ultrafiltration volume (l) 0.231 0.079 2.907 0.004 0.075 0.386 1.259 1.077 1.471
Dialysis vintage (months) 0.009 0.004 2.081 0.037 0.0004 0.018 1.009 1.0004 1.018
Abbreviations: SE standard error, Z Z score, CI confidence interval
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